Focus Stocks
Abbott Labs Close to the 50 Day
Published on Sunday, 22 January 2012 15:00 Written by Danny Miller
New York, January 22nd (TradersHuddle.com) - Shares of Abbott Laboratories (NYSE:ABT) closed the trading day at $55.76 close to its 50 day moving average currently set at $54.72. Abbott Labs' price action is just above this important support level translating into a trading opportunity.
Abbott Laboratories (NYSE:ABT) develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors. The company was founded in 1888 and is based in Abbott Park, Illinois.
Looking at peaks and troughs horizontal support and resistance levels, we can see current calculated support at $48.96 and calculated resistance at $56.84. These levels should also be evaluated by traders when planning their trades, as they provide an insight into the latest price action.
Traders wanting to establish a position on Abbott Labs will be looking at the price action for evidence of buying near the 50 day moving average, and opening a position as close as possible to this important level. Also traders will be looking at the latest price action, via the stocks current range previously defined for insights of other key levels that might affect their upside or downside.
Related Articles
- Abbott Launches PediaSure SideKicks® Clear for Picky Eaters
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada
- Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
- Abbott Reaches Settlement Agreement on Depakote
- Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury
- Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
- Abbott to Present at Deutsche Bank 37th Annual Health Care Conference
- New Products from Abbott's EAS® Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals
- Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States
Related Partner Headlines
- Abbott Laboratories (ABT): Today's Featured Drugs Loser - TheStreet.com
- Abbott Laboratories (ABT): Today's Featured Health Care Winner - TheStreet.com
- Abbott Helps Big Pharma Look Even Worse - TheStreet.com
- Abbott Laboratories (ABT): Today's Featured Health Care Loser - TheStreet.com
- Abbott Reaches Settlement Agreement on Depakote; Will Pay Total of $1.6B - Benzinga
- 10 Best-Performing 'Dividend Aristocrats' - TheStreet.com
- Abbott to Acquire Action Pharma's Investigational Compound, AP214 for $110M - Benzinga
- Abbott Stock Hits New 52-Week High (ABT) - TheStreet.com
- Pfizer Nears Deals for Nutrition, Animal Health Units: Report - TheStreet.com
- More Hep C Drug Abstracts Leak Ahead of EASL Confab - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com -
One Emotional Market - TheStreet.com -
Mixed Signals Emerge From Bakken Shale - TheStreet.com -
The Five Dumbest Things on Wall Street This Week: May 25 - TheStreet.com -
Carl Icahn Rumors Aren't a Reason to Buy Chesapeake Energy - TheStreet.com -
5 Things You Should Know Before the Stock Market Opens - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus -
Continental Resources Names Kirk Kinnear as Vice President of Oil Marketing Logistics -
Charm Communications to Present at Three Conferences in June -
Senior Management at UVMF Prepares to Pitch Some Big Ideas to Facebook -
XPO Logistics to Participate in Investor Conferences -
IntercontinentalExchange Announces Record Brent Crude Option Volume -
Grand Reopening Weekend Set for Newly Remodeled Life Time Fitness Six Forks Center May 26-27 -
Unwired Planet Takes Flight With a Tribute to Our Inventors and Their Impact on the Mobile Internet









